FDA Using GMP Head Count Method That May Shorten Compliance Schedules

Despite industry opposition, FDA will likely stick with an approach to assessing a firm's size that would count some small or medium-sized dietary supplement firms as larger, significantly shortening their schedule to comply with dietary supplement good manufacturing practices, officials say

More from Archive

More from Pink Sheet